# LifeStance Health

> LifeStance Health is a US outpatient mental healthcare company combining therapy, psychiatry, medication management, psychological testing and selected specialty treatments through local centers and telehealth. Its model pairs employed clinicians and supported practices with centralized administrative services and insurance reimbursement.

- **Founded:** 2017
- **Headquarters:** Scottsdale, United States
- **Founders:** Michael K. Lester (Co-founder; founding Chief Executive Officer), Gwen H. Booth (Co-founder; former Chief Operating Officer), Danish J. Qureshi (Co-founder; former Chief Growth Officer and Chief Operating Officer)
- **Products:** Talk therapy, Psychiatry and medication management, Psychological and neuropsychological testing, Telehealth, Specialty treatments
- **Notable:** Listed on Nasdaq as LFST in June 2021., Completed 9.0 million patient visits in 2025., Reported $9.7 million GAAP net income for full-year 2025.

## Products & services

- **Talk therapy** — Individual, couples, family, group and age-specific outpatient therapy, with availability varying by clinician and location.
- **Psychiatry and medication management** — Psychiatric evaluation and ongoing medication care through in-person and eligible virtual appointments.
- **Psychological and neuropsychological testing** — Diagnostic assessments, including ADHD and autism evaluations where available.
- **Telehealth** — Video appointments alongside the physical-center network; rapidly expanded in March 2020.
- **Specialty treatments** — Selected locations offer TMS, Spravato and medically monitored ketamine services; treatment eligibility and availability vary.

## Achievements

- Listed on Nasdaq as LFST in June 2021.
- Completed 9.0 million patient visits in 2025.
- Reported $9.7 million GAAP net income for full-year 2025.
- Reached 8,542 clinicians at June 30, 2026.
- Published a 2026 analysis of symptom outcomes in a follow-up cohort exceeding 180,000 patients; company-reported observational results do not establish comparative superiority.

## Latest updates

- **2026-10** — Announced that third-quarter 2026 results would be released November 5; those results were still pending as of October 23.
- **2026-09** — Selling shareholders priced a secondary offering of 22.25 million shares; this is distinct from new primary company funding.
- **2026-08** — Q2 revenue reached $435.4 million with $23.6 million net income; full-year revenue guidance increased to $1.685-$1.725 billion, a forecast rather than an achieved result.
- **2026-08** — LifeStance Health Foundation announced a renewed AFSP research partnership and a $100,000 award.
- **2026-03** — Published a depression and anxiety outcomes analysis using PHQ-9 and GAD-7 follow-up measures.

## Links

- Website: https://lifestance.com
- LinkedIn: https://www.linkedin.com/company/lifestance-health/
- Twitter/X: https://x.com/lifestanceUS
- YouTube: https://www.youtube.com/@lifestance_health
- Instagram: https://www.instagram.com/lifestancehealth/
- Facebook: https://www.facebook.com/lifestancehealth/
- TikTok: https://www.tiktok.com/@lifestancehealth

---

Profile page: https://yespress.io/lifestance-health
Published by YesPress — https://yespress.io
Last updated: 2026-10-23